NANO-X IMAGING news

The company is expanding its commercial presence in Latin America with its third market entry this year, demonstrating successful regional growth strategy and market penetration. The partnership with an established CCSS-registered supplier strengthens distribution capabilities and access to national healthcare purchasers.

Nanox secured a new distribution partnership with an established regional provider, expanding its U.S. commercial footprint and market access for the Nanox.ARC system. This represents strategic progress in their channel partner strategy and measured adoption efforts.

The company is the subject of a securities class action lawsuit alleging material misstatements regarding operational efficiency and product demand. The lawsuit claims the company concealed poor manufacturing alignment with demand, excessive cash burn, and the need for significant restructuring, resulting in investor losses.

The company faces a securities fraud lawsuit alleging material misstatements about operational efficiency and product demand. A significant $33.4 million net loss with $17.5 million in impairment charges, CFO departure, and 24.4% stock price decline indicate serious operational and financial problems.

Company is subject to securities class action lawsuit alleging material misstatements regarding operational efficiency, product demand, and financial performance. Allegations include overstated gains, poor manufacturing alignment, increased cash burn, and need for disruptive restructuring measures, indicating significant operational and financial problems.

The company is the subject of a securities fraud class action lawsuit alleging material misstatements about operational efficiency and demand. The disclosure of a $17.5 million impairment charge, manufacturing restructuring, and CFO departure resulted in a 24.39% stock price decline, indicating significant negative developments and investor losses.

The company is the subject of a securities fraud lawsuit alleging material misstatements regarding product demand and operational efficiency. The allegations indicate poor customer alignment and increased cash burn, resulting in investor losses.

The company is the subject of a securities class action lawsuit alleging material misstatements regarding operational efficiency, product demand, manufacturing alignment, and financial health. Allegations of overstated gains, increased cash burn, and need for disruptive restructuring indicate serious operational and disclosure failures.

The company is the subject of a securities fraud class action alleging material misstatements about operational efficiency and product demand. Nano-X reported significant losses, impairment charges, and restructuring costs, along with CFO resignation, indicating serious operational and financial challenges.

The company is the subject of a securities class action lawsuit alleging material misstatements regarding operational efficiency and product demand, along with concealment of poor manufacturing alignment, increased operating expenses, and significant cash burn requiring restructuring. These allegations indicate serious operational and disclosure failures that harmed investors.

The company is the subject of a securities class action lawsuit alleging material misstatements regarding operational efficiency, product demand, and financial health. Allegations include overstated efficiency gains, poor manufacturing alignment with demand, increased operating expenses, and significant cash burn requiring restructuring and impairment charges.

The company is the subject of a securities fraud class action lawsuit alleging material misstatements about operational efficiency and product demand, with claims of poor manufacturing alignment, increased operating expenses, and significant cash burn. These allegations suggest serious operational and financial problems.

Company disclosed a $17.5 million long-lived asset impairment charge and announced closure of its South Korean chip manufacturing facility, resulting in a 24.39% single-day stock decline. Securities class action alleges misrepresentations about manufacturing efficiency and product demand, indicating significant operational and financial challenges.

The company is the subject of a securities class action lawsuit alleging material misstatements regarding operational efficiency, product demand, and financial health. Allegations include overstated efficiency gains, poor manufacturing alignment with demand, increased operating expenses, significant cash burn, and undisclosed need for restructuring—all indicating serious operational and disclosure failures that harmed investors.

The company is accused of securities fraud through false statements about operational efficiency and product demand while concealing manufacturing problems and cash burn. A significant stock price decline of 24.39% followed the disclosure of a $33.4 million quarterly loss with $17.5 million in impairment charges, and the CFO stepped down, all indicating serious operational and financial distress.

The company is accused of securities fraud through false statements about operational efficiency and product demand while concealing manufacturing problems and financial deterioration. A significant stock price decline (24.39%) followed the disclosure of substantial losses and asset impairment charges, indicating serious operational and financial distress.

Company is subject to securities class action lawsuit alleging material misstatements regarding operational efficiency, product demand, manufacturing alignment, and financial health. Allegations of overstated gains and concealed cash burn indicate significant corporate governance and disclosure failures.

Alleged overstatement of operational efficiency and product demand, with poor manufacturing alignment, increased cash burn, and anticipated restructuring charges.

Subject of class action lawsuit alleging false statements regarding operational efficiency and cash burn between March 31, 2025 and April 17, 2026, indicating potential financial mismanagement and investor losses.

The company is accused of making false and misleading statements regarding operational efficiency and product demand, while concealing poor manufacturing alignment, increased operating expenses, and significant cash burn. These allegations suggest material misrepresentation to investors and operational challenges requiring restructuring.

The company is facing a securities fraud lawsuit alleging material misstatements about operational efficiency and product demand. Additionally, Nano-X disclosed significant financial losses ($33.4M net loss in Q4 2025), a $17.5M impairment charge, manufacturing restructuring, CFO departure, and experienced a sharp 25% stock price decline following the disclosure.

The company is the subject of a securities class action lawsuit alleging material misstatements regarding operational efficiency, product demand, and financial health. Allegations include overstated efficiency gains, poor manufacturing alignment with demand, increased operating expenses, and significant cash burn requiring restructuring.

The company is accused of issuing materially false and misleading statements about operational efficiency and product demand while concealing poor manufacturing alignment, increased expenses, and significant cash burn. These allegations suggest serious corporate governance failures and potential fraud, resulting in shareholder losses.

Class action alleges defendants overstated operational efficiency gains and product demand while concealing poor manufacturing alignment, increased operating expenses, and potential restructuring charges.

The company is the subject of a class action lawsuit alleging material misstatements about operational efficiency and product demand. Financial results revealed significant losses, impairment charges, and a 25% stock price decline, indicating serious operational and financial challenges.

Company reported significant quarterly losses ($33.4M), substantial asset impairment charges ($17.5M), facility restructuring, CFO departure, and is subject to a securities investigation for potential violations of federal securities laws. Stock experienced a sharp 25% decline following the announcement.

Company reported significant quarterly losses ($33.4M), substantial asset impairment charges ($17.5M), CFO departure, securities fraud investigation, and sharp stock price decline (24.39%), indicating serious operational and financial challenges.

Company reported significant quarterly losses ($33.4M), substantial asset impairment charges ($17.5M), facility restructuring, CFO departure, and faces potential securities law violations investigation. Stock declined 25% on announcement, indicating severe loss of investor confidence.

The company faces a fraud investigation for potentially issuing false or misleading statements, reported a significant $17.5 million impairment charge, experienced CFO departure, and saw a sharp 25% stock price decline, all indicating serious operational and governance concerns.

Company reported significant quarterly losses ($33.4M), substantial asset impairment charges ($17.5M), facility restructuring, CFO departure, and is now subject to a federal securities investigation. Stock price declined 25% on announcement, indicating severe investor concern and potential regulatory/legal issues.

The company is mentioned as having an ongoing securities class action lawsuit with an important deadline, suggesting similar allegations of investor harm and potential disclosure violations.

Company is subject to class action lawsuit filed by Pomerantz LLP alleging securities fraud or unlawful business practices, though specific details are not provided in the article excerpt.

Company is subject to securities class action lawsuit, indicating alleged material misstatements or omissions that harmed investors during the class period.

Company is subject to securities class action lawsuit; specific allegations not detailed in provided excerpt but implied similar misconduct as other defendants.

A new class action lawsuit has been filed alleging securities fraud violations with a lead plaintiff deadline of 8/11/2026.

Subject of ongoing securities class action investigation by Rosen Law Firm, indicating alleged shareholder losses and potential securities violations.